| AA | allergic asthma |
| AHR | airway hyperresponsiveness |
| AIT | allergen immunotherapy |
| AR | allergic rhinitis |
| ARA | atopic respiratory allergy |
| BAC | bronchial allergen challenge |
| BAT | basophil activation test |
| BD test | bronchodilator test |
| ECP | eosinophil cationic protein |
| εCSR | class switch recombination to IgE |
| FcεRI | high affinity receptor for IgE |
| FeNO | fractional exhaled nitric oxide |
| FEV1 | forced expiratory volume in the 1st second |
| FnNO | fractional nasal nitric oxide |
| GINA | global initiative for asthma |
| HC | healthy non-atopic control |
| HDM | house dust mite |
| ICSIg | inhaled corticosteroidsimmunoglobulin |
| IL | interleukin |
| IL-4Rα | α subunit of IL-4 receptor |
| IL-5Rα | α subunit of IL-5 receptor |
| LAA | local allergic asthma |
| LAR | local allergic rhinitis |
| LRA | local respiratory allergy |
| NAC | nasal allergen challengenasal allergen challenge |
| NAR | non-allergic rhinitis |
| NK cell | natural killer cell |
| SQ-HDM | standardized quality brand-specific unit denoting the biological power of the extract |
| SCIT | subcutaneous immunotherapy |
| sIgE | allergen-specific IgE |
| sIgG4 | allergen-specific IgG4 |
| SLIT | sublingual immunotherapy |
| SPT | skin prick test |
| sT cell | allergen-specific T cell |
| sTh2 cell | allergen-specific Th2 cell |
| T2 | type 2 inflammation |